Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hibiki Udagawa

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2021
[Comprehensive Genomic Analysis for Small Cell Lung Cancer]Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2017
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastasesHibiki Udagawa, Seiji Niho, Keisuke Kirita, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2024
Integrated analysis of older adults and patients with renal dysfunction in the IMpower130 and IMpower132 randomized controlled trials for advanced non-squamous non-small cell lung cancerMakoto Nishio, Satoshi Watanabe, Hibiki Udagawa, et al.
Respiratory Investigation|May 17, 2018
Patient-oriented optimal depth of conscious sedation using midazolam during flexible bronchoscopy: A prospective open-labeled single-arm trialYuichiro Takeda, Hibiki Udagawa, Shinji Nakamichi, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2019
Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specifiedTakahiro Ota, Keisuke Kirita, Reiko Matsuzawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 12, 2014
[Additional external radiotherapy to multiple metastases originating from thymic neuroendocrine tumor following peptide receptor radionuclide therapy: a case report]Takatsugu Kawase, Kazuo Kubota, Yuichiro Takeda, et al.
Cell Death & Disease|August 9, 2024
Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancerMotohiro Izumi, Masanori Fujii, Ikei S Kobayashi, et al.
Pathology International|July 25, 2019
Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer-associated fibroblasts with EGFR-TKI resistance-promoting phenotype: A study of 18 cases of cancer-associated fibroblastsErika Suzuki, Shota Yamazaki, Tomoyuki Naito, et al.
JTO Clinical and Research Reports|March 14, 2023
The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion MutationsYosuke Kagawa, Takuma Hayashida, Jie Liu, et al.
Medicine|February 1, 2018
Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancerKakeru Hisakane, Kiyotaka Yoh, Naoki Nakamura, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2021
[Comprehensive Genomic Analysis for Small Cell Lung Cancer]Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2017
Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastasesHibiki Udagawa, Seiji Niho, Keisuke Kirita, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2024
Integrated analysis of older adults and patients with renal dysfunction in the IMpower130 and IMpower132 randomized controlled trials for advanced non-squamous non-small cell lung cancerMakoto Nishio, Satoshi Watanabe, Hibiki Udagawa, et al.
Respiratory Investigation|May 17, 2018
Patient-oriented optimal depth of conscious sedation using midazolam during flexible bronchoscopy: A prospective open-labeled single-arm trialYuichiro Takeda, Hibiki Udagawa, Shinji Nakamichi, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2019
Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specifiedTakahiro Ota, Keisuke Kirita, Reiko Matsuzawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 12, 2014
[Additional external radiotherapy to multiple metastases originating from thymic neuroendocrine tumor following peptide receptor radionuclide therapy: a case report]Takatsugu Kawase, Kazuo Kubota, Yuichiro Takeda, et al.
Cell Death & Disease|August 9, 2024
Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancerMotohiro Izumi, Masanori Fujii, Ikei S Kobayashi, et al.
Pathology International|July 25, 2019
Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer-associated fibroblasts with EGFR-TKI resistance-promoting phenotype: A study of 18 cases of cancer-associated fibroblastsErika Suzuki, Shota Yamazaki, Tomoyuki Naito, et al.
JTO Clinical and Research Reports|March 14, 2023
The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion MutationsYosuke Kagawa, Takuma Hayashida, Jie Liu, et al.
Medicine|February 1, 2018
Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancerKakeru Hisakane, Kiyotaka Yoh, Naoki Nakamura, et al.
Pageof 6